Tanvex BioPharma, Inc. (TPE:6541)

Taiwan · Delayed Price · Currency is TWD

54.80

+2.30 (4.38%)

Aug 14, 2025, 1:30 PM CST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Biopharmaceuticals	61.41M	Log In	Log In	Log In
Biopharmaceuticals Growth	174.11%	Log In	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Taiwan	53.70M	Log In	Log In	Log In
Taiwan Growth	139.70%	Log In	Log In	Log In
United States	7.71M	Log In	Log In	Log In